| Medication management during pregnancy: role of the pharmacist. | |
| | |
MedLine Citation:
|
PMID: 21915759 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
A community pharmacist is frequently the first healthcare professional who is asked to give advice regarding medication use during pregnancy. As 50% of pregnancies are unplanned, a woman often discovers she is pregnant while already taking a medication and visits a pharmacy which is easily accessible, to enquire if she has harmed her baby by this action. Following a review of the literature, of which there is a paucity on this topic, we found that pharmacists often do not feel equipped to dispense teratology information and frequently refer the woman to her attending physician, without giving any information. In addition, it was clear that even when they did give information, it was not necessarily evidence-based and at times, inaccurate and based on their own opinions. In this article, we have attempted to make pharmacists aware of all the sources that are available, to enable them to perform this important role as a member of the health care team. These include websites, texts, evidence-based literature, teratogen information services and more. With the knowledge extracted from various resources, following critical appraisal of the data, they should be more comfortable and feel better equipped to transfer this information to a pregnant woman. In conclusion, while there may be a lack of adequate information regarding use of certain medications during pregnancy, pharmacists should be able to integrate available information with their medication expertise, to make appropriate individual risk/benefit decisions. This requires active engagement with pregnant women, rather than automatically referring them to their physician, thus establishing the pharmacist role as an essential member of the health care team. |
| | |
Authors:
|
Nardin Samuel; Adrienne Einarson |
Related Documents
:
|
2053229 - Multiparametric evaluation of testicular atrophy due to varicocele. 11935569 - The americans with disabilities act: implications of supreme court decisions for case m... 3875259 - The hypertrophied antral-pyloric fold. 10177749 - Revised medical criteria for determination of disability, endocrine system and related ... 21702949 - The evolution of health policy guidelines for assisted reproduction in the republic of ... 2714209 - Developmental toxicity testing with fetax: evaluation of five compounds. 3740579 - New concepts in triage. 9743789 - Expectations and opinions of pregnant women about medical students being involved in ca... 16315619 - Future needs and wants in medical education--the upm experience. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-14 |
Journal Detail:
|
Title: International journal of clinical pharmacy Volume: - ISSN: 2210-7711 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101554912 Medline TA: Int J Clin Pharm Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
The Motherisk Program, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Teaching enthesis ultrasound: experience of an ultrasound training workshop.
Next Document: Assessing the Genotoxic Potential of Chlorothalonil Drift from Potato Fields in Prince Edward Island...